It has been established that the most clinically aggressive subtypes of breast cancer, are also associated with EGFR overexpression (29, 30), while in ERα-positive breast cancer, IGF-IR is present at high levels and its action is correlated to ER status (31). The gene discussed is ESR1; the disease is breast cancer.